# Church & Dwight Co., Inc. (CHD)

> Source: Nexqual · https://nexqual.com/CHD · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Church & Dwight Co., Inc. (CHD), nexqual.com/CHD" · informational, not investment advice.

**Price:** USD 108.86 (+3.68% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 105 · day 105.67–108.93 · 52w 81.33–108.93 · market cap $25.8B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $6.23B, net income $745M (12.0% margin) (SEC filings).
- Valuation: P/E 34.7x (avg 34.3x at the last 3 fiscal year-ends), EV/EBITDA 21.4x, net debt $2.00B.
- 2 of 80 tracked superinvestors hold CHD (13F, Q2 2026): 0 new, 0 added, 2 reduced, 0 unchanged.
- Analysts: Hold (mean 2.57 on a 1–5 scale) (21 analysts), mean target USD 104.63 (range 78–115).
- Total return with dividends: 1Y +27.2% vs S&P 500 +14.9%; 5Y +36.5% vs S&P 500 +80.3%.
- Next earnings: 2026-10-30, EPS estimate USD 0.9, revenue estimate $1.58B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.19B | $5.38B | $5.87B | $6.11B | $6.20B | $6.23B |
| Gross profit | $2.26B | $2.25B | $2.59B | $2.79B | $2.77B | — |
| Operating income | $1.08B | $598M | $1.06B | $807M | $1.08B | $1.09B |
| Net income | $828M | $414M | $756M | $585M | $737M | $745M |
| EPS (diluted) | $3.32 | $1.68 | $3.05 | $2.37 | $3.02 | — |
| Free cash flow | $875M | $706M | $807M | $976M | $1.09B | — |
| Gross margin | 43.6% | 41.9% | 44.1% | 45.7% | 44.7% | — |
| Operating margin | 20.8% | 11.1% | 18.0% | 13.2% | 17.4% | 17.5% |
| Net margin | 15.9% | 7.7% | 12.9% | 9.6% | 11.9% | 12.0% |
| Revenue growth | +6.0% | +3.6% | +9.2% | +4.1% | +1.6% | — |
| Cash + short-term investments | $241M | $270M | $345M | $964M | $409M | — |
| Total debt | $2.90B | $2.60B | $2.40B | $2.20B | $2.21B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 34.7x · P/S 4.2x · EV/EBITDA 21.4x · EV/Sales 4.5x · P/B 5.9x · Earnings yield 2.88% · Dividend yield (paid, TTM) 1.12% · Net debt $2.00B · EV $27.8B
P/E at fiscal year-ends: Dec 2025 27.8x, Dec 2024 44.2x, Dec 2023 31.0x.

## Superinvestors (SEC 13F-HR, Q2 2026)
2 of 80 tracked investors hold CHD. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Terry Smith | Fundsmith | 4.58% | $626M | Reduced -2.8% |
| Jensen Investment Management |  | 0.07% | $3.1M | Reduced -8.1% |

## Analysts
Consensus Hold (mean 2.57 on a 1–5 scale), 21 analysts; mean target USD 104.63 (low 78, high 115).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-16 | Barclays | Target lowered | Underweight | $86 → $83 |
| 2026-10-05 | Wells Fargo | Target lowered | Overweight | $110 → $105 |
| 2026-08-03 | UBS | Target raised | Neutral | $104 → $107 |
| 2026-08-03 | Citigroup | Target raised | Neutral | $100 → $105 |
| 2026-08-03 | TD Cowen | Target raised | Hold | $95 → $97 |
| 2026-08-03 | RBC Capital | Target raised | Outperform | $114 → $115 |
| 2026-07-21 | Barclays | Target raised | Underweight | $79 → $86 |
| 2026-07-16 | JP Morgan | Target raised | Neutral | $99 → $105 |
| 2026-07-16 | UBS | Target raised | Neutral | $100 → $104 |
| 2026-07-08 | Wells Fargo | Target raised | Overweight | $105 → $110 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +27.2% | +36.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +27.3% | +6.4% |
| Volatility (annualized) | 22.9% | 19.7% |
| Max drawdown | -13.8% (Feb 2026→May 2026) | -31.6% (Jan 2022→Oct 2022) |

## Peers (Household & Personal Products)
KMB (Kimberly-Clark Corporation) USD 112.32 +5.32% · KVUE (Kenvue Inc.) USD 19.88 +4.41% · EL (Estee Lauder Companies, Inc. (T) USD 107.72 +3.92% · CLX (Clorox Company (The)) USD 88.66 +4.59% · CL (Colgate-Palmolive Company) USD 97.39 +4.27% · ELF (e.l.f. Beauty, Inc.) USD 114.99 +1.06%

## More
Full page: https://nexqual.com/CHD · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in CHD's own 10-K filed 2026-02-12 (https://www.sec.gov/Archives/edgar/data/313927/000119312526048139/chd-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Walmart (WMT) | "In each of the years ended December 31, 2025, 2024 and 2023, net sales to our largest customer, Walmart Inc. and its affiliates ("Walmart"), were approximately 23% of our consolidated net sales." |
| Customer | Visa (V) | "Our website ecommerce and customer relations businesses that store, process or transmit payment cardholder data are subject to be Payment Card Industry (PCI) compliance requirements as mandated by the credit card compani…" |
| Customer | Mastercard (MA) | "Our website ecommerce and customer relations businesses that store, process or transmit payment cardholder data are subject to be Payment Card Industry (PCI) compliance requirements as mandated by the credit card compani…" |
| Competitor | Procter & Gamble (PG) | "Our competitors in the Consumer Domestic and Consumer International segments include, among others, Procter & Gamble Company ("P&G"), The Clorox Company, Colgate-Palmolive Company, S.C." |

## Revenue by business segment (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY | Operating income | Op. margin |
|---|---|---|---|---|---|
| Consumer Domestic | $1.16B | 75.5% | +0.1% | $223.4M | 19.3% |
| Consumer International | $297.5M | 19.4% | +7.2% | $41.6M | 14.0% |
| Specialty Products Division | $76.7M | 5.0% | +2.8% | $11.4M | 14.9% |
| Total revenue | $1.53B | 100% | — | $276.4M | 18.1% |

## Revenue by product line (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Household Products | $662.0M | 43.3% | +1.8% |
| Personal Care Products | $493.8M | 32.3% | -2.0% |
| Total revenue | $1.53B | 100% | — |
The lines above cover 75.5% of total revenue.

## Customer concentration

Period ended 2025-12-31: 23% of revenue from unnamed direct customers (10-K, filed 2026-02-12).

## Company outlook (8-K filed 2026-07-31)

- "Full Year Outlook • Net Sales +1.6% Reflecting Strategic Portfolio Actions • Organic Sales +5.8%: Domestic +5.1% | Int'l +9.1% | SPD +2.8%¹ • Gross Margin 45.4%;"
- "Net sales increased 1.6% to $1,530.0 million in the second quarter, exceeding the Company's outlook of a 1% decline and reflecting the benefits of its successful 2025 strategic portfolio actions."
- "Organic sales growth accelerated to 5.8%, well above the Company's 3% outlook, with growth across all three divisions, driven primarily by volume growth of 4.3% and positive price and mix of 1.5%."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.90 | $0.94 | -3.8% | $1.58B | 16 |
| Next quarter (ends 2026-12-31) | $1.03 | $0.99 | +4.6% | $1.67B | 15 |
| Current fiscal year (ends 2026-12-31) | $3.77 | $3.77 | +0.0% | $6.24B | 18 |
| Next fiscal year (ends 2027-12-31) | $4.03 | $4.05 | -0.4% | $6.51B | 18 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-10-30): ±6.5%; last 8 reports averaged ±3.8%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 25.5% | ±6.5% |
| 2026-12-18 | 56 | 23.5% | ±7.5% |
| 2027-01-15 | 84 | 21.3% | ±8.3% |
| 2027-04-16 | 175 | 21.4% | ±11.9% |